Wanrudee Isaranuwatchai


Affiliate Scientist


Dr. Wanrudee Isaranuwatchai is an Affiliated Scientist at St. Michael’s Hospital, and an Associate Professor at the Institute of Health Policy, Management and Evaluation, University of Toronto, in Canada. She is also a Program Leader and Senior Researcher of the Health Intervention and Technology Assessment Program (HITAP), Thailand.

Her research focuses on how to apply health economics and health technology assessment (HTA) in the real-world setting as well as how to advance methods in economic evaluation (EE). She has experience conducting EEs using various methods with specific interest in the potential of big data in health economics and HTA to support evidence generation and policy-making process.

She has also collaborated with researchers, health professionals, and policy-makers in various areas to help communicate the value of health initiatives using EE. She has contributed to the training on HTA to support health systems in Asia, Africa, and North America. Dr. Isaranuwatchai is dedicated to the creation and use of evidence in healthcare decision making.

Recent Publications

  1. Kc, S, Faradiba, D, Sittimart, M, Isaranuwatchai, W, Ananthakrishnan, A, Rachatan, C et al.. Factors associated with the opposition to COVID-19 vaccination certificates: A multi-country observational study from Asia. Travel Med Infect Dis. 2022;48 :102358. doi: 10.1016/j.tmaid.2022.102358. PubMed PMID:35595199 PubMed Central PMC9113761.
  2. Marzouk, M, Omar, M, Sirison, K, Ananthakrishnan, A, Durrance-Bagale, A, Pheerapanyawaranun, C et al.. Monitoring and Evaluation of National Vaccination Implementation: A Scoping Review of How Frameworks and Indicators Are Used in the Public Health Literature. Vaccines (Basel). 2022;10 (4):. doi: 10.3390/vaccines10040567. PubMed PMID:35455316 PubMed Central PMC9032699.
  3. McGavock, J, Hobin, E, Prior, HJ, Swanson, A, Smith, BT, Booth, GL et al.. Multi-use physical activity trails in an urban setting and cardiovascular disease: a difference-in-differences analysis of a natural experiment in Winnipeg, Manitoba, Canada. Int J Behav Nutr Phys Act. 2022;19 (1):34. doi: 10.1186/s12966-022-01279-z. PubMed PMID:35346244 PubMed Central PMC8962160.
  4. Saunders, H, Pham, B, Loong, D, Mishra, S, Ashoor, HM, Antony, J et al.. The Cost-Effectiveness Of Intermediate-Acting, Long-Acting, Ultralong-Acting, and Biosimilar Insulins for Type 1 Diabetes Mellitus: A Systematic Review. Value Health. 2022; :. doi: 10.1016/j.jval.2021.12.016. PubMed PMID:35341688 .
  5. Udayakumar, S, Solomon, E, Isaranuwatchai, W, Rodin, DL, Ko, YJ, Chan, KKW et al.. Cancer treatment-related financial toxicity experienced by patients in low- and middle-income countries: a scoping review. Support Care Cancer. 2022; :. doi: 10.1007/s00520-022-06952-4. PubMed PMID:35322274 .
  6. Teerawattananon, Y, Anothaisintawee, T, Pheerapanyawaranun, C, Botwright, S, Akksilp, K, Sirichumroonwit, N et al.. A systematic review of methodological approaches for evaluating real-world effectiveness of COVID-19 vaccines: Advising resource-constrained settings. PLoS One. 2022;17 (1):e0261930. doi: 10.1371/journal.pone.0261930. PubMed PMID:35015761 PubMed Central PMC8752025.
  7. Zanoni, P, Scime, NV, Benzies, K, McNeil, DA, Mrklas, K, Alberta FICare in Level II NICU Study Team et al.. Facilitators and barriers to implementation of Alberta family integrated care (FICare) in level II neonatal intensive care units: a qualitative process evaluation substudy of a multicentre cluster-randomised controlled trial using the consolidated framework for implementation research. BMJ Open. 2021;11 (10):e054938. doi: 10.1136/bmjopen-2021-054938. PubMed PMID:34663673 PubMed Central PMC8524282.
  8. Boulos, MI, Kamra, M, Colelli, DR, Kirolos, N, Gladstone, DJ, Boyle, K et al.. SLEAP SMART (Sleep Apnea Screening Using Mobile Ambulatory Recorders After TIA/Stroke): A Randomized Controlled Trial. Stroke. 2022;53 (3):710-718. doi: 10.1161/STROKEAHA.120.033753. PubMed PMID:34628939 .
  9. Mendlowitz, A, Bremner, KE, Walker, JD, Wong, WWL, Feld, JJ, Sander, B et al.. Hepatitis C virus infection in First Nations populations in Ontario from 2006 to 2014: a population-based retrospective cohort analysis. CMAJ Open. ;9 (3):E886-E896. doi: 10.9778/cmajo.20200164. PubMed PMID:34584007 PubMed Central PMC8486470.
  10. Mendlowitz, A, Bremner, KE, Walker, JD, Wong, WWL, Feld, JJ, Sander, B et al.. Health care costs associated with hepatitis C virus infection in First Nations populations in Ontario: a retrospective matched cohort study. CMAJ Open. ;9 (3):E897-E906. doi: 10.9778/cmajo.20200247. PubMed PMID:34584004 PubMed Central PMC8486469.
Search PubMed

Affiliations & Other Activities

  • Scientist, Li Ka Shing Institute
  • Assistant Professor, Institute for Health Policy, Management and Evaluation, University of Toronto